发明名称 |
Cochleate compositions directed against expression of proteins |
摘要 |
Disclosed herein are novel siRNA-cochleate and morpholino-cochleate compositions. Also disclosed are methods of making and using siRNA-cochleate and morpholino-cochleate compositions. |
申请公布号 |
US9259392(B2) |
申请公布日期 |
2016.02.16 |
申请号 |
US201314038810 |
申请日期 |
2013.09.27 |
申请人 |
RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY |
发明人 |
Gould-Fogerite Susan;Mannino Raphael J.;Ahl Patrick;Shang Gaofeng;Chen Zi Wei;Krause-Elsmore Sara L. |
分类号 |
C12N15/11;A61K9/127;A61K31/7048;C12N15/113;A61K38/00 |
主分类号 |
C12N15/11 |
代理机构 |
MH2 Technology Law Group, LLP |
代理人 |
MH2 Technology Law Group, LLP |
主权项 |
1. An siRNA-cochleate composition comprising:
a cochleate; and an siRNA associated with the cochleate, wherein the cochleate comprises a negatively charged lipid component and a multivalent cation component, wherein the siRNA is complexed with a transfection agent prior to contacting a liposome, wherein the transfection agent is a cationic transfection agent. |
地址 |
New Brunswick NJ US |